Table 1.
Condition | Cell/Tissue | Species | MDP family member | Findings | Refs |
---|---|---|---|---|---|
Myocardial fibrosis | Cardiac tissue | Mice | HNG | Attenuation of myocardial fibrosis | [84] |
Cardiomyopathy | Cardiac tissue | Mice | HNG | Cardiac protection and preserved mitochondrial function. | [92] |
Cardiac ischemia-reperfusion (I/R) injury induced brain dysfunction | Cardiac tissue, Brain | Rats | HNG | Attenuated mitochondrial dysfunction and reduced brain susceptibility to apoptosis. | [93] |
Myocardial I/R injury | Cardiac tissue | Rats | HNG | Decreased cardiac arrhythmia, myocardial infarct size, mitochondrial dysfunction, and left ventricular dysfunction. | [94] |
Cardiovascular disease | Cardio myoblasts | Mice | HNG | Removal of abnormal proteins via chaperone-mediated autophagy. | [91] |
Myocardial ischemia and reperfusion | Myocardium cell line, cardiac tissue | Mice | HNG | Cardio protection, decrease in infarct size and improvement in ventricular function | [95] |
Cerebrovascular diseases | Cardiac tissue. Neuronal cells | Mice | HNG | Removal of abnormal proteins via chaperone-mediated autophagy | [91] |
Cardiovascular disease | Platelets | Mice | HNG | Attenuated cremaster arterial thrombus formation | [96] |
Aging | C. elegans | Worm | HN | Increased lifespan | [97] |
Cancer | Blood plasma, testes | Mice | HNG | Cytoprotection of germ cells and leukocytes and non-cancerous cells in tumor-bearing mice. | [98] |
Neuroblastoma or medulloblastoma | Growth plate tissues/metatarsal bones/tumor xenografts | Human, Mice |
HNG | Prevention of bone growth impairment and chondrocyte apoptosis | [99] |
Cancer | Breast cancer cells | Human, Mice | HN | Pro-tumoral effects | [100] |
Cancer and fertility | Blood, liver, spleen, testes | Mice | HNG | Amelioration of chemotherapy-induced germ cell apoptosis; WBC and granulocyte loss. | [101] |
Neurodegenerative diseases. | Neuroblastoma cell line (SH-SY5Y). | Human | HN-silver Nanoparticles | Neuroprotection | [102] |
Alzheimer's disease | Cortical neurons | Rats | HN | Attenuation of NMDA- excitotoxicity, improvement of mitochondrial function | [103,104] |
Alzheimer's disease | Brain | Mice | HNG | Improved cognitive function | [105,106] |
Alzheimer's disease | Brain | Rats | HNG | Reversal of impairment of spatial memory | [107] |
Alzheimer's disease | Brain | Mice | HNG | Decreased Aβ level and ameliorated cognitive impairment. | [108] |
Alzheimer's disease | Brain | Rats | HN | Amelioration of memory deficits induced by Aβ (1-42). | [109] |
Glucocorticoid-induced Bone growth impairment | Metatarsal bones/growth plate biopsies/chondrocytes | Rats, Human, HN-Tg mice |
HN | Prevention of GC-induced growth impairment in cultured bones | [110] |
Arthritis | Articular and growth plate cartilage | Mice | HNG | Decreased chondrocyte apoptosis | [110] |
Stroke | Brain | Mice | HN | Reduction of neurological deficits, and improved hematoma clearance | [83] |
Endothelial dysfunction | Umbilical vein endothelial cells | Human | HNG | Decrease in lipid aggregation and apoptosis | [76] |
Obesity | Plasma | Mice | HNG | Regulation of glutathione and sphingolipid metabolism | [111] |
Atherosclerosis/diabetes | Umbilical vein endothelial cells | Human | HN | Prevention of hyperglycemia-associated endothelial dysfunction | [112] |
Diabetes | Umbilical vein endothelial cells | Human | HNG | Reduction in apoptosis induced by high glucose | [113] |
Diabetes | Beta-cells/NOD mice | Mice | HN | Decreased apoptosis and delayed onset of diabetics | [79] |
Diabetes | Liver | Rats | HNGF6A | Lowering of blood glucose | [78] |
Atherosclerosis | Proximal aorta | Mice | HNGF6A | Improved endothelial function and impaired progression of atherosclerosis | [114] |
Age-related diseases | NIT-1 murine β-cells, prostate carcinoma cell line | Mice, human | SHLP2 | Increased glucose uptake and suppressed hepatic glucose production. | [59] |
Obesity | Plasma | Mice | SHLP2 | Regulation of glutathione and sphingolipid metabolism | [111] |
Diet-induced obesity | HEK293, HeLa cells, Liver, skeletal muscle | Human, Mice |
MOTS-c | Reduction of obesity | [58] |
HFD-induced hyperinsulinemia | Liver | Mice | MOTS-c | Attenuated hyperinsulinemia | [58] |
Ovariectomy‐induced osteoporosis | Bone | Mice | MOTS-c | Alleviated bone loss | [115] |
Osteolysis | Primary bone marrow macrophages, bone | Mice | MOTS-c | Alleviated bone erosion and inflammation. | [116] |
Hypothermia | Plasma, liver | Mice | MOTS-c | Increased activation of adipose thermogenesis | [117] |
Bone fracture | Bone Marrow Mesenchymal Stem Cells | Rats | MOTS-c | Accelerated bone fracture healing | [118] |
Endothelial dysfunction | Aortic rings, renal artery stenosis | Rats, mice | MOTS-c | Improved endothelial function | [119] |